Endothelial dysfunction and atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease

被引:10
作者
Ciftel, Murat [1 ]
Simsek, Ayse [1 ]
Turan, Ozlem [1 ]
Kardelen, Firat [1 ]
Akcurin, Gayaz [1 ]
Ertug, Halil [1 ]
机构
[1] Akdeniz Univ, Dept Pediat Cardiol, Fac Med, Antalya, Turkey
关键词
Childhood; congenital heart disease; flow-mediated dilatation; pulmonary hypertension;
D O I
10.4103/0974-2069.99619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess endothelial dysfunction and the risk for coronary atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease (CHD). Methods: The study included 18 cyanotic patients (the mean age was 12.28 3.26 years) who developed irreversible pulmonary hypertension due to cyanotic and acyanotic CHDs, and 18 control patients (the mean age was 11.78 3.00 years). Study groups were compared for flow-mediated dilatation (FMD), carotid intima media thickness (CIMT) and atherosclerotic risk factors. Results: Compared to the control group, the mean FMD was significantly reduced in the cyanotic group (5.26 2.42% and 9.48 2.60%, respectively; P-value < 0.001). No significant difference was observed between the groups in CIMT (0.41 0.08 mm and 0.39 0.06 mm, respectively; P-value = 0.299). The levels of total cholesterol, low-density lipoprotein-cholesterol and very low-density lipoprotein-cholesterol were statistically significantly lower compared tothe control group (P-value = 0.001, 0.006 and 0.014, respectively), whereas no statistically significant difference was found in the levels of high-density lipoprotein-cholesterol and triglycerides (P-value = 0.113 and 0.975, respectively). Conclusions: Systemic endothelial dysfunction in children with irreversible pulmonary hypertension due to CHD was noted but there was no increased risk for atherosclerosis.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 25 条
  • [1] Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice
    Barton, M
    Haudenschild, CC
    D'Uscio, LV
    Shaw, S
    Münter, K
    Lüscher, TF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) : 14367 - 14372
  • [2] NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS
    CELERMAJER, DS
    SORENSEN, KE
    GOOCH, VM
    SPIEGELHALTER, DJ
    MILLER, OI
    SULLIVAN, ID
    LLOYD, JK
    DEANFIELD, JE
    [J]. LANCET, 1992, 340 (8828) : 1111 - 1115
  • [3] Chronic cyanosis and vascular function: implications for patients with cyanotic congenital heart disease
    Cordina, Rachael L.
    Celermajer, David S.
    [J]. CARDIOLOGY IN THE YOUNG, 2010, 20 (03) : 242 - 253
  • [4] Eisenmenger syndrome - Factors relating to deterioration and death
    Daliento, L
    Somerville, J
    Presbitero, P
    Menti, L
    Brach-Prevert, S
    Rizzoli, G
    Stone, S
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 (12) : 1845 - 1855
  • [5] de Soares RPS, 2005, CARDIOL YOUNG, V15, P504
  • [6] Atherosclerosis in Patients With Cyanotic Congenital Heart Disease
    Duffels, Marielle G. J.
    Mulder, Karlijn M.
    Trip, Mieke D.
    de Groot, Erik
    Gort, Johan
    van Dijk, Arie P. J.
    Hoendermis, Elke S.
    Daliento, Luciano
    Zwinderman, Aeiko H.
    Berger, Rolf M. F.
    Mulder, Barbara J. M.
    [J]. CIRCULATION JOURNAL, 2010, 74 (07) : 1436 - 1441
  • [7] Eisenmenger V., 1897, Z KLIN MED S, V32, P1
  • [8] Ferreiro CR, 2001, CIRCULATION, V103, P2272
  • [9] Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes - Further evidence for the existence of the "vulnerable" patient
    Fichtlscherer, S
    Breuer, S
    Zeiher, AM
    [J]. CIRCULATION, 2004, 110 (14) : 1926 - 1932
  • [10] Cyanotic congenital heart disease and coronary artery atherogenesis
    Fyfe, A
    Perloff, JK
    Niwa, K
    Child, JS
    Miner, PD
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (02) : 283 - 290